Spondylometaphyseal dysplasia with combined immunodeficiency (Q57461): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 05:06, 14 August 2026
Spondylometaphyseal dysplasia with combined immunodeficiency is characterised by combined immunodeficiency, autoimmunity (that manifests as vitiligo, Crohn's disease, arthritis, thyroiditis, and thrombocytopenia), and spondylometaphyseal dysplasia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_687261501 |
||
| English | Spondylometaphyseal dysplasia with combined immunodeficiency |
Spondylometaphyseal dysplasia with combined immunodeficiency is characterised by combined immunodeficiency, autoimmunity (that manifests as vitiligo, Crohn's disease, arthritis, thyroiditis, and thrombocytopenia), and spondylometaphyseal dysplasia. |
Statements
CID11:ID_687261501
0 references
dki-india-ID_687261501
0 references
Concluído
0 references
13 August 2026
0 references
